Prof. Dr. Dagmar Fischer

Functions

• Chair holder of Pharmaceutical Technology
• Vice Director of the Jena Center for Soft Matter (JCSM)

Research

• Natural and Synthetic Polymers as Drug Delivery Systems
• Bacterial Nanocellulose as Drug Delivery System
• Nanosafety, Biocompatibility and Risk Management of Materials; Alternatives to Animal Experiments (3R Concepts)
• NanoBel InflammAging

Publications (selected 5 most recent)

1. T. Bellmann, J. Thamm, U. Beekmann, D. Kralisch, D. Fischer, In situ formation of polymer microparticles in bacterial nanocellulose using alternative and sustainable solvents to incorporate lipophilic drugs, Pharmaceutics, 15 (2023) 559. DOI: 10.3390/ pharmaceutics15020559
2. A. Czapka, C. Grune, P. Schädel, V. Bachmann, K. Scheuer, M. Dirauf, C. Weber, A.L. Skaltsounis, K.D. Jandt, U.S. Schubert, D. Fischer, O. Werz. Drug delivery of 6-bromoindirubin-3’-glycerol-oxime ether employing poly(d,l-lactide-co-glycolide)-based nanoencapsulation techniques with sustainable solvents, J. Nanobiotechnology, 20 (2022) 1-21. DOI: 10.1186/s12951-021-01179-7
3. M. Rabel, P. Warncke, M. Thürmer, C. Grüttner, C. Bergemann, H.D. Kurland, F.A. Müller, A. Koeberle, D. Fischer, The differences of the impact of a lipid and protein corona on the colloidal stability, toxicity, and degradation behavior of iron oxide nanoparticles. Nanoscale 13 (2021) 9415-9435. DOI: 10.1039/D0NR09053K
4. C. Grune,C. Zens,A. Czapka,K. Scheuer,J. Thamm, S. Hoeppener, K.D. Jandt,O. Werz,U. Neugebauer, D. Fischer, Sustainable preparation of anti-inflammatory atorvastatin PLGA nanoparticles, Int. J. Pharmaceutics, 599 (2021) 120404. DOI: 10.1016/j.ijpharm.2021.120404
5. F. Hack, C. Cokca, S. Städter, J. Hülsmann, K. Peneva, D. Fischer, Indole, Phenyl, and Phenol Groups: The Role of the Comonomer on Gene Delivery in Guanidinium Containing Methacrylamide Terpolymers, Macromolecular Rapid Communications 42 (2021) 5920. DOI: 10.1002/marc.202170025